Tel Aviv / Zurich, 28 June 2017 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN,
OTCPK: SMDCY) (“SHL”), a leading provider and developer of advanced personal telemedicine
solutions, announced that at the Special General Meeting of the Shareholders which was held
today in Tel-Aviv, Israel, the following Independent (external) directors of the Board were
elected, each for a three (3) year term: Mr. Yehoshua Abramovich and Mr. Xuequan Qian. For
resumes of the new Board members please refer to SHL’s website at www.shl-
telemedicine.com
For more information Click here
Facebook
Twitter
LinkedIn
Pinterest
